SCHEMBL13707463

SCHEMBL13707463

Cc1ccc2c(c1)sc1cc(C(C)C)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.42
NPC1 O15118 5/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
SCN4A P35499 1/20 0.42
BCL2L1 Q07817 1/20 0.40
MCL1 Q07820 1/20 0.40
LMNA P02545 3/20 0.39
TRPA1 O75762 2/20 0.38
PTGS1 P23219 1/20 0.38
CACNA1C Q13936 1/20 0.38
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
KIF11 P52732 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 4/20 0.35
GAA P10253 3/20 0.35
CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13084833 0.90 RAB9A (0.48) RAB9ANPC1SMN1; SMN2SCN4ALMNA
SCHEMBL2756756 0.89 RAB9A (0.40) RAB9ANPC1SMN1; SMN2SCN4ABCL2L1
SCHEMBL812518 0.83 BCL2L1 (0.50) RAB9ANPC1SMN1; SMN2BCL2L1MCL1
SCHEMBL9980171 0.82 KDM4E (0.41) RAB9ANPC1BCL2L1MCL1MAPT
SCHEMBL16622747 0.82 KDM4E (0.41) RAB9ANPC1SMN1; SMN2SCN4ABCL2L1
SCHEMBL13772192 0.81 LMNA (0.39) RAB9ANPC1SMN1; SMN2SCN4ALMNA
SCHEMBL13338346 0.81 GPR3 (0.54) RAB9ANPC1SMN1; SMN2SCN4ALMNA
SCHEMBL19602883 0.80 NPC1 (0.39) RAB9ANPC1SMN1; SMN2SCN4ALMNA
SCHEMBL12109032 0.79 BCL2L1 (0.47) RAB9ANPC1SMN1; SMN2BCL2L1MCL1
SCHEMBL12797460 0.79 BCL2L1 (0.47) RAB9ANPC1SMN1; SMN2BCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016083303-A1 PREPARATION OF POLYMERS COMPRISING AT LEAST ONE BENZO[C][1,2,5]THIADIAZOL-5,6-DICARBONITRILE-UNIT BASF SE (DE) 2016-06-02 WO disclosed
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-09-17 US disclosed
US-20090189519-A1 Organic electroluminescent compounds and light emitting diode using the same GRACEL DISPLAY INC. (KR) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090189519-A1 Organic electroluminescent compounds and light emitting diode using the same OCIAD1, AOX1, OCIAD2 RAB9A 2158/4885NPC1 390/4885SMN1; SMN2 3577/4885
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OXER1, L1CAM, RPL41 RAB9A 2994/4885NPC1 2149/4885SMN1; SMN2 2627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.